Jun 18, 2020 by James HalleyZynex Soared Last Week. But Is It a Risky Buy?Zynex climbed to record highs on Thursday, but there are reasons to pump the brakes on this medical equipment company.
Jun 15, 2020 by James HalleyThese 2 Stocks Are Cleaning Up Thanks To Medical Mask Sterilization. Are They Buys?Steris and Fortive are on the rise, thanks in part to their medical devices used to decontaminate N95 or N95-equivalent respirators.
Jun 14, 2020 by James Halley3 Pot Stocks to Stay Miles Away FromThere are good marijuana stocks out there, but these Canadian cannabis companies have serious red flags.
Jun 14, 2020 by James HalleyWhich Stock Will Bounce Back Best: Medtronic or Boston Scientific?The pandemic has slowed sales for the two medical device companies. Which stock is ready to rise when medical procedures return?
Jun 8, 2020 by James HalleyIs Cresco Labs a Risky Buy?The Chicago company's growth may allow it to be a cannabis survivor. Here's what investors need to know.
Jun 7, 2020 by James HalleyBetter Buy: AbbVie vs. Johnson & JohnsonWhich of these pharmaceutical giants is more likely to provide investors with big gains in 2020?
Jun 5, 2020 by James HalleyGot $1,000? Buy These 3 Medical Distributor StocksThese three companies dominate the industry, and all provide growth with a nice dividend.
Jun 3, 2020 by James Halley3 Stocks to Buy Ahead of the Next Market CrashThe global pandemic has shown us that certain stocks do better than others coming out of a market decline.
Jun 3, 2020 by James HalleyIs It Too Late to Jump In on Zentalis?The company's share price has nearly tripled since its IPO less than two months ago. Is it too late to get in on the fun?
Jun 2, 2020 by James Halley3 Pet Med Stocks That Offer Growth and a Nice DividendSpending on pet health continues to climb. Investors should consider buying PetMed Express, Phibro Animal Health, and Merck & Co.
May 31, 2020 by James HalleyWhy Align Technology Remains a Good Investment OpportunityThe maker of Invisalign aligners had a tough first quarter because of the COVID-19 pandemic, but the company is poised for a breakout.
May 28, 2020 by James HalleyHologic Is Trading Near Its All-Time High. Is It Still a Good Buy?The company's COVID-19 testing platform is just part of the reason for the stock's jump.
May 28, 2020 by James Halley3 Reasons Why Biohaven Pharmaceuticals' Stock Is Taking OffA hot new migraine drug, positive financials, and several promising drug candidates in late-stage trials are luring investors to this stock.
May 24, 2020 by James Halley3 Medical-Supply Stocks You Should Own Besides MedtronicMSA Safety, Fresnius Medical Care, and LeMaitre Vascular are well-priced stocks on the rise with solid dividends.
May 23, 2020 by James HalleyFDA Approval Could Be a Game-Changer for Deciphera PharmaceuticalsApproval of its cancer-fighting drug could make all the difference.
May 21, 2020 by James HalleyWill Good News Boost This Small-Cap Drug Company's Stock Even Higher?A do-over on one of its drugs is a potential game-changer for CymaBay.
May 20, 2020 by James HalleyIs Green Thumb Worth a Second Look?With climbing revenue and lowered losses, this company may be a cannabis survivor.
May 16, 2020 by James HalleyCan Pfizer's Stock Keep Climbing?This may be a good buying opportunity for a sleeping pharmaceutical giant that should rise this year.
May 15, 2020 by James Halley3 Telehealth Stocks I Like Better Than TeladocTeladoc is hot right now, but bigger players are in a better position to benefit from the rise of telehealth.
May 14, 2020 by James HalleyIs Now a Good Time To Buy Neurocrine Biosciences?The biopharmaceutical company has seen shares rise 44.5% in less than two months.
